GlassScriptFidia Pharma USA INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$355Kgeneral payments (2019-2025)
$0.00research payments (2019-2025)
7,797clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
- Hymovis $117K associated (2023-2025)
- Triluron $73K associated (2023-2025)
- Hyalgan $27K associated (2023-2025)
- Hyalo4 Care Hydrogel $9,124 associated (2023-2025)
- Hym/Hyn $5,351 associated (2023-2025)
- Richplat Ortho Prp System $3,804 associated (2023-2025)
- Hymhyn $3,047 associated (2023-2025)
- Hyalo4care $3,000 associated (2023-2025)
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Eric Lullove | Coconut Creek, FL | Foot & Ankle Surgery | $9,143.14 |
| Todd Stitik | Newark, NJ | Pain Medicine (Physical Medicine & Rehabilitation) | $8,098.75 |
| Bradley Glodny | New York, NY | Dermatology | $5,127.26 |
| Jonathan Saluta | Los Angeles, CA | Surgery | $4,896.17 |
| Manuj Singhal | Flower Mound, TX | Orthopaedic Surgery | $4,141.97 |
| Matthew Bassan | Wayne, NJ | Sports Medicine (Family Medicine) | $3,661.45 |
| Michael Odonnell | Iowa City, IA | Urology | $3,600.00 |
| Gerard Malanga | Cedar Knolls, NJ | Physical Medicine & Rehabilitation | $3,551.95 |
| Sean Whalen | New York, NY | Nuclear Medicine | $3,288.74 |
| David Goldberg | Miami, FL | Gastroenterology (Internal Medicine) | $3,000.00 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.